EXECUTIVE ENGAGEMENTS
POOL
12652
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1518
Interactions with Platform & by Email
PARTICIPANTS
382
Unique # Participated
VALIDATIONS
77
Responses Validated*
COMPANIES
47
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
231
PAGES
308
EDITION
7
PRICE
USD 5450
CODE
MCP10863
*Engagement stats are ongoing and dynamic
Login to access data silos
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Cancer Diagnostics estimated at US$150.6 Billion in the year 2020, is projected to reach a revised size of US$223.3 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Laboratory Tests, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$50.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Tests segment is readjusted to a revised 6.4% CAGR for the next 7-year period.
The Cancer Diagnostics market in the U.S. is estimated at US$40.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$46.7 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
In the global Imaging segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.4 Billion in the year 2020 will reach a projected size of US$41.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$30.1 Billion by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period.
SELECT PLAYERS
Abbott Diagnostics; Abbott Laboratories; Agilent Technologies, Inc.; Ambry Genetics Corporation; Applied Imaging; AstraZeneca PLC; AutoGenomics, Inc.; BARD, A Becton, Dickinson Company; Bayer AG; Becton, Dickinson and Company; BioCurex, Inc.; bioMeriux SA; Celara Diagnostics; Diagnostic Products Corporation; Eli Lilly and Company; F. Hoffmann-La Roche AG; GE Healthcare; Genoptix, Inc.; GlaxoSmithKline PLC; Hologic, Inc.; Illumina, Inc.; Pfizer, Inc.; Philips Healthcare; QIAGEN GmbH; Siemens Healthineers; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian, Other Applications) » Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy, Other Types)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Genetic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Skin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Prostate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ovarian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Cancer Diagnostics by Type - Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Other Types for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Cancer Diagnostics by Application - Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 47 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com